Webinar Outline:

• Navigating progress and challenges in TCE development

• Introducing next-generation models such as PBMC-NCG, PBMC-NCG-MHC-DKO and huHSC-NCG

• Discussing innovative safety assessment strategies using CD3EDG humanized systems and HSC-reconstituted models

• Presenting integrated in vitro and in vivo preclinical evaluation solutions for TCEs

For more information, please contact sales@gempharmatech.com